Voyageur Pharmaceuticals (CVE:VM) Shares Down 37.5% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price fell 37.5% during mid-day trading on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.15. 1,401,125 shares were traded during trading, an increase of 162% from the average session volume of 534,757 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Performance

The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The business has a 50 day moving average price of C$0.10 and a 200 day moving average price of C$0.07. The stock has a market cap of C$23.01 million, a P/E ratio of -16.50 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.